https://www.medscape.com/viewarticle/982778
0
0
32 words
0
Comments
Researchers in Germany report a 10-day post-vaccination hold on methotrexate boosts immunity against Omicron without compromising safety or risk of disease flares.
You are the first to view
Create an account or login to join the discussion